Form 4: BioRestorative Therapies VP of Research and Development Reports Changes in Beneficial Ownership
SEC Form 4
Francisco Silva, VP of Research and Development at BioRestorative Therapies, reports changes in beneficial ownership, including the acquisition of stock options.
Summary
- Francisco Silva, the VP of Research and Development at BioRestorative Therapies, Inc., filed a Form 4 with the SEC.
- The report details changes in his beneficial ownership of the company's securities.
- Silva acquired stock options for 768,979 shares of common stock on February 14, 2025, with an exercise price of $0.
- These options vest in installments, starting with 384,490 shares on February 14, 2025, and the remaining 384,489 shares vesting in eight quarterly installments beginning February 14, 2026.
- The report also lists existing direct and indirect holdings of common stock and other stock options with varying exercise prices and vesting schedules.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating changes in ownership, with the acquisition of stock options by an executive potentially viewed as a slightly positive signal.
Positives
- The acquisition of stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the ownership stake of a key executive.
Key Dates
| Date | Description |
|---|---|
| 02/17/2023 | 53,381 shares of stock options vest |
| 02/13/2024 | 197,369 shares of stock options vest |
| 02/17/2024 | 53,381 shares of stock options vest in eight nearly equal quarterly installments beginning on this date |
| 02/14/2025 | Date of transaction; 384,490 shares of stock options vest |
| 02/13/2025 | 197,368 shares of stock options vest in eight nearly equal quarterly installments beginning on this date |
| 02/14/2026 | 384,489 shares of stock options vest in eight nearly equal quarterly installments beginning on this date |
| 09/04/2025 | Expiration date for stock options for 6 shares |
| 06/10/2026 | Expiration date for stock options for 15 shares |
| 07/12/2027 | Expiration date for stock options for 20 shares |
| 10/29/2028 | Expiration date for stock options for 25 shares |
| 03/18/2031 | Expiration date for stock options for 293,479 shares |
| 11/04/2031 | Expiration date for stock options for 42,059 shares |
| 02/17/2033 | Expiration date for stock options for 106,762 shares |
| 02/13/2034 | Expiration date for stock options for 394,737 shares |
| 02/14/2035 | Expiration date for stock options for 768,979 shares |
| 02/18/2025 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.